The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis

Natalia I Díaz-Valdivia1, Jorge Díaz1,2, Pamela Contreras1

  • 1Cellular Communication Laboratory, Center for studies on Exercise, Metabolism and Cancer (CEMC), Advanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Oncogene
|March 11, 2020
PubMed

Insights

The protein tyrosine phosphatase PTPN14 dephosphorylates caveolin-1 (CAV1), inhibiting cancer cell migration and metastasis. Overexpressing PTPN14 reduces CAV1

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Caveolin-1 (CAV1) promotes cancer cell migration, invasion, and metastasis.
  • E-cadherin co-expression inhibits CAV1's metastasis-promoting functions, but the mechanism is unclear.
  • The interaction between CAV1, E-cadherin, and β-catenin in metastasis regulation requires further elucidation.

Purpose of the Study:

  • To identify proteins interacting with CAV1 in the presence of E-cadherin.
  • To investigate the role of protein tyrosine phosphatase PTPN14 in CAV1-mediated metastasis.
  • To determine if PTPN14 can regulate CAV1 activity and cancer cell behavior.

Main Methods:

  • Mass spectrometry to analyze protein complexes involving CAV1.
  • Co-immunoprecipitation and Western blotting to confirm protein interactions.
  • Functional assays measuring cell migration, invasion, and Rac-1 activation.
  • In vivo metastasis assays in a murine melanoma model.

Main Results:

  • The protein tyrosine phosphatase PTPN14 was identified in CAV1 immunoprecipitates when E-cadherin was co-expressed.
  • PTPN14 directly interacts with CAV1, and this interaction is independent of E-cadherin for the CAV1(Y14F) mutant.
  • Overexpression of PTPN14 reduced CAV1 phosphorylation, suppressed CAV1-enhanced cell migration, invasion, and Rac-1 activation, and inhibited metastasis in vivo.

Conclusions:

  • CAV1 is a novel substrate for the protein tyrosine phosphatase PTPN14.
  • PTPN14 negatively regulates CAV1 activity and suppresses its pro-metastatic functions.
  • PTPN14 overexpression is sufficient to reduce CAV1-induced metastasis, highlighting its therapeutic potential.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K